These results indicate that DSD drugs may act on AKT1, EGFR, TP53, and TNF through formononetin, isorhamnetin, β-Sitosterol, and kaempferol, thereby playing a role in treating MI. The gene discussed is AKT1; the disease is myocardial infarction.